Dynamic List Information
Dynamic List Data
Title
Issuance of Clinical Laboratory Improvement Amendments of 1988 (CLIA) State Agency Performance Review (SAPR)—Fiscal Year 2024 (FY 2024)
Memo #
Admin Info: 24-23-CLIA
Posting Date
2024-09-26
Fiscal Year
2024
Summary
Memorandum Summary
• The Centers for Medicare & Medicaid Services (CMS) is releasing the FY 2024 guidance for the State Agency Performance Review (SAPR).
• CLIA SAPR Review Protocol: The FY 2024 review has been updated from FY 2023. We are updating three documents to improve readability and ease by which SAs may complete the templates: the FY 2024 SAPR Excel Workbook, the FY 2024 Summary Report, and the FY 2024 CLIA SAPR Cover Letter CAP Resp Template.
• Goal: The purpose of the SAPR is to ensure optimal State Agency (SA) performance to improve quality in patient laboratory testing and promote health and safety.
• Review of Other Subject Areas: CMS’s Division of Clinical Laboratory Improvement and Quality (DCLIQ) has the overarching responsibility and authority for SA oversight, which is neither superseded nor limited by the CLIA SAPR. Subject areas not specifically addressed by the FY 2024 Review Criteria may also be reviewed at CMS DCLIQ’s discretion.
• The Centers for Medicare & Medicaid Services (CMS) is releasing the FY 2024 guidance for the State Agency Performance Review (SAPR).
• CLIA SAPR Review Protocol: The FY 2024 review has been updated from FY 2023. We are updating three documents to improve readability and ease by which SAs may complete the templates: the FY 2024 SAPR Excel Workbook, the FY 2024 Summary Report, and the FY 2024 CLIA SAPR Cover Letter CAP Resp Template.
• Goal: The purpose of the SAPR is to ensure optimal State Agency (SA) performance to improve quality in patient laboratory testing and promote health and safety.
• Review of Other Subject Areas: CMS’s Division of Clinical Laboratory Improvement and Quality (DCLIQ) has the overarching responsibility and authority for SA oversight, which is neither superseded nor limited by the CLIA SAPR. Subject areas not specifically addressed by the FY 2024 Review Criteria may also be reviewed at CMS DCLIQ’s discretion.